2023-09-29 04:30:00
Developed by the Sanofi group, Beyfortus has met with unexpected success. Authorized on the European market since 2022, this preventive treatment against respiratory tract infections in newborns and infants is so popular that doses are already starting to run out. At its launch, the State had ordered 200,000 doses, for 120,000 births over the year, counting on a smooth start to the first immunization campaign which began on September 15.
However, it turns out that young parents, far from being resistant to this preventive treatment against bronchiolitis, have…
1695963292
#Lorraine #Immunization #babies #bronchiolitis #victim #success
Related posts:
NHL: 30th goal in 30 games for Tage Thompson in Sabers win
Goodbye Chivas? Alexis Vega in the sights of Tigres, would pay a million! Halftime
Discover the power of these 5 medicinal plants as a natural remedy for health
Flandriennes, Giro, Tour de France: the 2023 calendar through the crossover between van Aert and Eve...
Why Size Doesn't Matter: Montreal Canadiens' Suzuki and Caufield's Playoff Success
Will Aster Vranckx Leave Wolfsburg? Latest Transfer News and Updates
Al-Ghandoura Donia Batma loses her mind and abandons her lower clothes completely in the most shocki...
If unknown bruises appear on your body, refer to the doctor immediately, which may indicate